ArticleAmerican journal of translational research2024

A comparative study of the efficacy and safety of PD-1/L1 inhibitor and platinum-containing dual-agent chemotherapy in patients with advanced non-small cell lung cancer resistant to EGFR-TKIs.

Chunhui Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.